Elamin YY, Robichaux JP, Carter BW, Altan M, et al. Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity. Cancer Cell 2022;40:754-767.
PMID: 35820397